content top

RSNA/ESR: Essentials in Oncologic Imaging—What Radiologists Need to Know: Part I.


8:30 AM- 12:15 PM

Code: SR41


The main objective of this session is to provide a practical, clinically-relevant summary of key imaging issues in common cancers using an interactive, case-based approach. It will also provide an overview of current cancer-related terminology, definitions and ‘buzz’ words used in everyday practice. Attendees will learn how imaging can optimally assess and measure tumor treatment response, providing a value-added radiology report.

This session includes eight sections; the first is Principles of and Reporting, which reviews general principles of oncologic imaging. IT will illustrate the critical importance of clinical context during interpretation of oncologic exams. This section discusses ways to ensure that our reports provide added value and reflect the radiologist’s role as consultant. The second section is Lung Cancers (Primary, Metastases), which reviews the strengths and limitations of radiologic techniques suitable for detecting and characterizing primary and metastatic lesions in the lungs. Attendees will understand the imaging findings relevant for lung cancer T, N and M staging, and appraise the implications of the new IASLC lung cancer staging system. This section discusses the imaging findings used to assess response to conventional and new therapies for lung cancers. The third section, Colon Cancer, is providing an overview of current recommendations for the diagnosis of colorectal cancer. Attendees will understand the specific role of MDCT, MR Imaging, endoscopic ultrasound, and PET/CT in the staging of colorectal cancer in optimizing patient management. They will also learn the utility of imaging in assessing tumor response to therapy and in the general follow up of patients with colorectal cancer. The fourth section is a question and answer session.

The fifth section is Pancreatic Cancer, in which attendees will understand current pathologic concepts for the classification of pancreatic tumors. This section describes imaging findings used for tumor detection, staging, and restaging after adjuvant therapy. Attendees are going to understand the role of functional and molecular information provided by PET/CT, DWI and perfusion imaging when assessing pancreatic tumors. The sixth section, Kidney Cancer, is including understanding of the diagnostic implications of minimally invasive treatments of renal cancer. The section reviews the genetic causes of renal cancer and the radiologic appearances of specific histologic subtypes. It will also review the potential role of molecular imaging in the management of advanced renal cancer. The seventh section is Ovarian Cancer, which provides an overview of the essential imaging findings in characterization and staging of ovarian cancer. Attendees will learn the key imaging findings that affect management of ovarian cancer. They will also understand the changes in imaging armamentarium in ovarian cancer, and learn the best practice in proper image utilization. The eighth and final section is another question and answer session.


Leave a Reply